BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 33714009)

  • 21. Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
    Argyris PP; Saavedra F; Malz C; Stone IA; Wei Y; Boyle WS; Johnstone KF; Khammanivong A; Herzberg MC
    Oral Oncol; 2023 Feb; 137():106304. PubMed ID: 36608459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma.
    Khlifi R; Rebai A; Hamza-Chaffai A
    J Genet; 2012; 91(3):375-84. PubMed ID: 23271025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
    Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
    Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.
    Kumar A; Pant MC; Singh HS; Khandelwal S
    Tumour Biol; 2012 Feb; 33(1):111-9. PubMed ID: 22081374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis.
    Vlachogiannis NI; Pappa M; Ntouros PA; Nezos A; Mavragani CP; Souliotis VL; Sfikakis PP
    Front Immunol; 2020; 11():582401. PubMed ID: 33123169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
    Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
    Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
    J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geriatric Frailty Is Associated With Oxidative Stress, Accumulation, and Defective Repair of DNA Double-Strand Breaks Independently of Age and Comorbidities.
    Kravvariti E; Ntouros PA; Vlachogiannis NI; Pappa M; Souliotis VL; Sfikakis PP
    J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):603-610. PubMed ID: 36209410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults.
    Kostrzewska-Poczekaj M; Gawęcki W; Illmer J; Rydzanicz M; Gajecka M; Szyfter W; Szyfter K
    Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):271-6. PubMed ID: 22427030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
    Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes.
    Qiao Y; Spitz MR; Shen H; Guo Z; Shete S; Hedayati M; Grossman L; Mohrenweiser H; Wei Q
    Carcinogenesis; 2002 Feb; 23(2):295-9. PubMed ID: 11872635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population.
    Liang Y; Zhang L; Chen Z; Chen J; Fang S; Zhang T; Zhu Y; Liu J; Li B; Shao Y; Xing J; Zhang S; Han P
    Dis Markers; 2022; 2022():4959737. PubMed ID: 36118674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.
    Hirakawa H; Ikegami T; Azechi S; Agena S; Uezato J; Kinjyo H; Yamashita Y; Tanaka K; Kondo S; Maeda H; Suzuki M; Gahana A
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):601-610. PubMed ID: 31749055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
    Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
    Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
    Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
    Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
    Todorovic V; Groselj B; Cemazar M; Prevc A; Zakelj MN; Strojan P; Sersa G
    Radiol Oncol; 2022 Apr; 56(2):173-184. PubMed ID: 35390246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.
    Chiang CC; Tsai YY; Bau DT; Cheng YW; Tseng SH; Wang RF; Tsai FJ
    Mol Vis; 2010 Apr; 16():698-704. PubMed ID: 20431719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.